112 related articles for article (PubMed ID: 165939)
1. The effect of cytostatic hexitol derivatives on haematopoietic stem cells, the L1210 leukaemia and C22LR osteosarcoma.
Fuzy M; Lelieveld P; Van Putten LM
Eur J Cancer (1965); 1975 Mar; 11(3):169-73. PubMed ID: 165939
[No Abstract] [Full Text] [Related]
2. The effect of dibromo-dulcitol, diepoxy dulcitol and various new cytostatic hexitol derivatives on the metabolic activities of nucleic acids and proteins--II.
Hidvégi EJ; Sebestyén J; Szabó LD; Köteles GJ; Institoris L
Biochem Pharmacol; 1976 Aug; 25(15):1705-10. PubMed ID: 942473
[No Abstract] [Full Text] [Related]
3. Pharmacologic and antitumor effects of 1,2:5,6-dianhydrogalactitol (NSC-132313).
Németh L; Institóris L; Somfai S; Gál F; Pályi I; Sugár J; Csuka O; Szentirmay Z; Kellner B
Cancer Chemother Rep; 1972 Oct; 56(5):593-602. PubMed ID: 4652589
[No Abstract] [Full Text] [Related]
4. 1,6-Di-O-methanesulphonyl-2,3-4,5-dianhydro-L-iditol, a new potential antitumour agent. Biological investigations.
Csányi E; Halász M
Arzneimittelforschung; 1973 Jul; 23(7):961-7. PubMed ID: 4356189
[No Abstract] [Full Text] [Related]
5. Clinical pharmacology of carbohydrate derivatives with cytostatic potency.
Eckhardt S
Adv Enzyme Regul; 1976; 14():297-311. PubMed ID: 788476
[No Abstract] [Full Text] [Related]
6. Toxicity, antitumour and haematological effects of 1,2-anhydro-6-bromogalactitol and d-mannitol: a comparison with the related dibromo- and dianhydro-derivatives.
Horváth IP; Somfai-Relle S; Hegedüs L; Jarman M
Eur J Cancer Clin Oncol; 1982 Jun; 18(6):573-7. PubMed ID: 6811281
[TBL] [Abstract][Full Text] [Related]
7. Biologic activity of two derivatives and six possible metabolites of cyclophosphamide (NSC-26271).
Lelieveld P; van Putten LM
Cancer Treat Rep; 1976 Apr; 60(4):373-9. PubMed ID: 1064468
[TBL] [Abstract][Full Text] [Related]
8. Dose and time dependent suppressive and enhancing effect of cytostatics in vitro on the target cell killing activity of lymphocytes.
Petrányi GG; Benczur M; Onódy K; Alföldy P
Folia Biol (Praha); 1973; 19(6):420-3. PubMed ID: 4205080
[No Abstract] [Full Text] [Related]
9. Inhibition of late splenic extra-colony formation by mitobronitol.
Gulya E; Kelemen E; Holló I
Ann N Y Acad Sci; 1985; 459():334. PubMed ID: 3938194
[No Abstract] [Full Text] [Related]
10. Experimental studies on the combination of radiation and chemotherapy.
Lelieveld P; Smink T; van Putten L
Int J Radiat Oncol Biol Phys; 1978; 4(1-2):37-41. PubMed ID: 273018
[No Abstract] [Full Text] [Related]
11. Potential antitumor agents. Some 1,6-disubstituted galactitol and mannitol derivatives.
Acton EM; Keyanpour-Rad M; Christensen JE; Tong HH; Kwok RP; Goodman L
Carbohydr Res; 1972 May; 22(2):477-86. PubMed ID: 5047748
[No Abstract] [Full Text] [Related]
12. Acute effect of endogenous inhibitors and exogenous cytostatics on the ultrastructure of bone marrow cells. I. Single dose of 1,2 : 5,6-dianhydrogalactitol (DAD).
Balázs A
Haematologia (Budap); 1976; 10(3-4):433-44. PubMed ID: 1028676
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological studies with alkylsulfonyloxyalkyl substituted and chloroethyl substituted oxazaphosphorine-2-oxides. 1. Communication: relationship between chemical structure and pharmacological action.
Brock N; Kuhlmann J
Arzneimittelforschung; 1974 Aug; 24(8):1139-49. PubMed ID: 4371234
[No Abstract] [Full Text] [Related]
14. Ftorafur: a self-limiting source of 5-fluorouracil?
van Putten LM; Lelieveld P; Pantarotto C; Salmona M; Spreafico F
Cancer Chemother Pharmacol; 1979; 3(1):61-6. PubMed ID: 119584
[No Abstract] [Full Text] [Related]
15. Amphotericin B potentiation of the cytotoxicity of anticancer agents against both normal hematopoietic and leukemia cells in mice.
Valeriote F; Medoff G; Tolen S; Dieckman J
J Natl Cancer Inst; 1984 Aug; 73(2):475-82. PubMed ID: 6589439
[TBL] [Abstract][Full Text] [Related]
16. Cell-cycle specificity and therapeutic effectiveness of cytostatic agents.
Van Putten LM; Lelieveld P; Kram-Idsenga LK
Cancer Chemother Rep; 1972 Dec; 56(6):691-700. PubMed ID: 4512950
[No Abstract] [Full Text] [Related]
17. Reduction of lethal toxicity of chloroethylnitrosoureas by sugar alcohols without loss of antitumor activity.
Tashiro T; Inaba M; Sakurai Y
Cancer Chemother Pharmacol; 1982; 8(2):183-8. PubMed ID: 6809355
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of antitumor agents administered subcutaneously to L1210 leukemic mice in silicone rubber devices.
Neil GL; Scheidt LG; Kuentzel SL; Moxley TE
Chemotherapy; 1973; 18(1):27-40. PubMed ID: 4681847
[No Abstract] [Full Text] [Related]
19. Evaluation of p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met-ethoxy HCl against transplantable and spontaneous murine neoplasia.
Yagi MJ; Bekesi JG
Cancer Chemother Pharmacol; 1990; 26(3):215-20. PubMed ID: 2357770
[TBL] [Abstract][Full Text] [Related]
20. Cell killing, kinetics, and recovery responses induced by 1,2:5,6-dianhydrogalactitol in dividing and nondividiing cells in vitro.
Barranco SC; Flournoy DR
J Natl Cancer Inst; 1977 Mar; 58(3):657-63. PubMed ID: 839561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
